Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Be better prepared for pandemics

The German Center for Infection Research (DZIF) and the Helmholtz Centre for Infection Research (HZI) have developed a concept to form a National Alliance for Pandemic Therapeutics (NA-PATH). They

Klebsiella pneumoniae
© NIAID

Quest for bacterial cocktails to fight infections

The intestine of a healthy person contains hundreds of different bacteria that provide efficient protection against infections. However, if the equilibrium of this community, known as the microbiota

DZIF Prizes for Translational Infection Research

The DZIF Academy is pleased to open the call for applications for two prizes in 2021: the DZIF Prize for Fundamental Translational Infection Research and the DZIF Prize for Clinical Translational

Escherichia coli
© NIAID

Alarming: Resistances against a new active-substance combination detectable prior to use in Germany

Enterobacteria such as Escherichia coli or Klebsiella pneumoniae are dreaded hospital germs that can cause serious intestinal and urinary tract infections. The risk of infection with these pathogens

Julia Pagel Preisverleihung
© C. Kloodt / Exzellenzcluster PMI, Uni Kiel

Julia Pagel honoured with the Dorothea Erxleben Female Investigator Award

Paediatrician and DZIF scientist Dr Julia Pagel, Universität zu Lübeck, will receive EUR 50,000 to expand her research on lung diseases in infants. The prize is awarded by the North German Cluster of

Staphyolococcus aureus
© NIAID

INCATE supports the fight against antibiotic-resistant bacteria

Multidrug-resistant bacteria are spreading worldwide, and new antibiotics and strategies against deadly infectious diseases are urgently needed. With INCATE (INCubator for Antibacterial Therapies in

Pipeline für neue Antibiotika
© mod. nach Nat Rev Chem (2021): https://doi.org/10.1038/s41570-021-00313-1

Fighting resistances: Concepts for new antibiotics

Increasingly insensitive to standard drugs: Multi-resistant pathogens are spreading worldwide and even in the near future could threaten the safe treatment of deadly infectious diseases. However, the

Impfstoffe
© fernando zhiminaicela auf Pixabay

Combination vaccines against Covid-19 tested

People under the age of 60 who initially received a vaccine from AstraZeneca should be given an mRNA vaccine at their second appointment. This is recommended by the German Standing Committee on

Acetat aktiviert das Immunsystem
© Universität Tübingen, Michael Pelzer

Tübingen research team develops new strategy against sepsis

Some cases of bloodstream infections are mild, but many have a fatal outcome – the reasons for these differences have remained in the dark despite decades of research. Researchers from the University

idt Abfüllanlage
© Hartmut Bösener/IDT Biologika

Study with optimized vector vaccine MVA-SARS-2-S resumed

The clinical review of the MVA-SARS-2-S vector vaccine against COVID-19 will continue with a new version. The DZIF (German Center for Infection Research) scientists temporarily suspended the study